Balance Sheet Data

Meridian Bioscience, Inc. (VIVO)

$25.77

-0.30 (-1.15%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 57.0759.7662.4053.5149.7789.23100.84113.95128.77145.51
Total Cash (%)
Account Receivables 29.1132.3435.6138.5153.5757.0364.4572.8382.3093
Account Receivables (%)
Inventories 41.4941.9939.6261.2676.8477.8587.9899.42112.34126.95
Inventories (%)
Accounts Payable 7.726.267.2411.9711.7013.4915.2417.2319.4722
Accounts Payable (%)
Capital Expenditure -4.47-4.20-3.80-3.30-18.31-9.44-10.67-12.06-13.62-15.40
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.